You are here: Industry Insights > gene

News List

Navigating the Neurodegenerative Crisis: A Multifaceted Approach Shruti Talashi
December 09, 2024
Overtaking more established issues like cancer and heart disease, neurological problems have become a major worldwide health concern.
Making Cell and Gene Therapy Affordable Suzanne Elvidge
November 04, 2024
Cell and gene therapies (CGTs) have revolutionised medicine, providing personalised and targeted treatment for life-limiting diseases from genetic disorders to hard-to-treat cance.However, these cutting-edge therapeutics can come with a high price tag.
Touchlight to Supply GMP dbDNA to Support University of Nottingham’s Clinical Study for a Next-Generation Vaccine for Zika Virus Biotech Newswire
August 22, 2024
Touchlight announced the clinical supply of its proprietary dbDNA™ to the University of Nottingham for research and development of a next-generation DNA vaccine targeting the Zika virus.
Gene Editing Destiny: The CRISPR Revolution and Beyond Shruti Talashi
August 01, 2024
Genome editing has the potential to eradicate hereditary illnesses, improve human potential, and transform biotechnology and agriculture with continued research and development.
British Journal of Cancer: Zurletrectinib Is a Next-Generation TRK Inhibitor With Strong Intracranial Activity Against NTRK Fusion-Positive Tumors With On-Target Resistance to First-generation Agents July 31, 2024
Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumors with on-target resistance to first-generation agents.
Dermaliq Therapeutics Announces Positive Topline Results from Phase 1b/2a Trial Evaluating the Safety and Efficacy of DLQ01 for the Treatment of Androgenetic Alopecia (AGA) in Men Biotech Newswire
July 17, 2024
DLQ01 is potentially the first new topical treatment option for both men and women suffering from AGA in a very long time.
Based on the Current Status of Drug Research and Development Targeting the Pathogenesis of Influenza (Part 2) Xiaomichong
July 12, 2024
Influenza is an acute respiratory infectious disease caused by the influenza virus.
Based on the Current Status of Drug Research and Development Targeting the Pathogenesis of Influenza (Part 1) Xiaomichong
July 12, 2024
Influenza is an acute respiratory infectious disease caused by the influenza virus.
Research Progress on the Pathogenesis and Clinical Diagnosis of Mycoplasma Pneumoniae Pneumonia Xiaomichong
June 26, 2024
Mycoplasmal Pneumonia Pneumonia (MPP), also known as primary atypical pneumonia or cold agglutinin-positive pneumonia, is a common respiratory disease among children caused by infection with Mycoplasmal pneumoniae (MP), which frequently occurs in school-a
Celonic Inaugurates “Next Generation” Biologics Development Center (BDC) and Pilot Plant in Basel, Switzerland Biotech Newswire
June 24, 2024
The Celonic Group, a Swiss Based Quality Biologics Contract Development and Manufacturing Organization (CDMO) today opened its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland.